Skip to main content
Request a Free Valuation
Published April 8, 2026Updated July 18, 2026

Medical-director and clinical-oversight continuity can become a material transaction issue when the relationship is undocumented, does not match actual operations, cannot continue after closing, or does not satisfy the law governing the services and providers involved.

This post is the framework. It covers why the question matters, how buyers actually evaluate it, what the workable solutions look like, and what to do if you are the medical director of your own practice.

A medical director becomes a transaction risk when the relationship is undocumented, non-transferable, under-scoped, owner-dependent, or unlikely to continue after closing. Buyers verify the director’s license, duties, compensation, supervision, records, agreement terms, and transition plan because a title alone does not prove clinical oversight or continuity.

Medical Director Risk Matrix

AreaWhat Buyers VerifyWarning SignSeller Preparation
AgreementExecuted term, duties, termination, assignment, and change-of-control termsHandshake arrangement or expired contractCurrent signed agreement and amendments
Actual dutiesProtocols, chart review, supervision, escalation, and availabilityAgreement does not match practiceEvidence of documented oversight
Licensing and state fitLicenses, location coverage, and state-specific requirementsCoverage gaps or incorrect jurisdictionLicense and location schedule
CompensationFee structure, invoices, and consistency with documented servicesUnclear economics or payments without recordsPayment history and service support
ContinuityWillingness and ability to remain after closingImmediate termination right or personal loyalty to sellerTransition discussion and backup plan
Provider concentrationRevenue and clinical dependence on one director or prescriberNo replacement pathwaySuccession and recruiting plan

Medical Director Continuity Plan

  1. Confirm the current agreement and real-world duties match.
  2. Identify every location, provider, and service dependent on the relationship.
  3. Review notice, termination, assignment, and change-of-control provisions with counsel.
  4. Discuss post-closing interest at the appropriate confidential stage.
  5. Prepare a qualified replacement path without disrupting current operations.

Medical director continuity connects directly to med spa ownership structure and the broader med spa due diligence checklist. Requirements differ by state; obtain qualified legal and clinical guidance.

Related Questions

  • Does a medical director agreement transfer to a buyer?
  • Can a med spa close if its medical director will not stay?
  • What evidence of oversight do buyers request?
  • How does compensation affect diligence?
  • When should a replacement plan be created?

Why Clinical-Oversight Continuity Matters

Whether a med spa needs a physician owner, medical director, supervising or collaborating physician, or another licensed-clinician structure depends on the state, provider licenses, services, delegation rules, and entity form. A medical-director title alone does not establish lawful ownership, delegation, supervision, or clinical control. The Medical Board of California’s med-spa guidance illustrates why state-specific review matters.

In a sale, buyers should determine which clinical roles and agreements must continue, be replaced, or be restructured under state-specific law. The role does not automatically “transfer” with the business.

The four scenarios

Almost every med spa sale falls into one of four medical director scenarios. They are not equally easy to sell.

Scenario 1 — Owner is a physician and is the medical director

Example: A dermatologist owns a practice that includes a med spa component. She is the medical director and the primary clinical operator.

The complication: When she sells, she is the medical director and the owner. The buyer needs both roles to transfer in a way that maintains continuity. Most buyers in this scenario want the owner-physician to stay on for 24–60 months post-close on a defined employment agreement, often with significant equity rollover.

Difficulty: Medium. Manageable with the right deal structure and the right buyer.

Scenario 2 — Owner is not a physician, has a long-tenured contracted medical director who will continue post-close

Example: A non-physician entrepreneur owns a multi-location group with a medical director who has been with the practice for five years and has signaled willingness to continue under a new owner.

The complication: Minimal, if the medical director is genuinely committed to staying. The buyer needs to confirm the relationship in diligence and (typically) negotiate a new contract directly with the medical director that aligns with the buyer’s structure.

Difficulty: Low. This is the cleanest scenario.

Scenario 3 — Owner is not a physician, has a contracted medical director who will not continue (or whose continuity is uncertain)

Example: The current medical director is approaching retirement, has signaled they want to exit when the owner does, or has an arms-length relationship that won’t transfer.

The complication: Significant. The buyer needs a successor medical director identified, credentialed in the relevant state(s), and contracted before the deal can close. Depending on the state and the specific situation, this can add 60–120 days to the closing timeline. If the buyer doesn’t have a designated physician relationship in the state, the timeline expands further.

Difficulty: Medium-high. Solvable but adds friction.

Scenario 4 — Owner is the medical director (non-physician owner with the owner functioning as the medical director through some informal or quasi-formal arrangement)

This scenario is rarer because it usually doesn’t pass scrutiny — but it does happen. The owner is the de facto operational head of the practice, the practice has a “medical director” on paper who is largely uninvolved, and the day-to-day clinical decisions are made by the owner (who is not a licensed physician) and the providers (who are licensed but typically NPs or PAs working under physician supervision).

The complication: Severe. A buyer’s diligence team will identify this immediately, and the structural issues will need to be cleaned up before close — sometimes in ways that change the fundamental economics of the practice. In some cases, the existing structure may have regulatory exposure that the buyer won’t take on.

Difficulty: High. Often requires significant restructuring before going to market, and sometimes affects whether the practice can be sold at all without first being remediated.

How buyers evaluate the medical director situation

Sophisticated buyers — particularly PE-backed platforms — go through a defined checklist. The questions are roughly:

1. Who is the medical director today?

  • Owner physician, employed physician, contracted physician, shared physician
  • License status, time with the practice, age, retirement timeline
  • Compensation arrangement and how it would transfer

2. What are the state-specific CPOM requirements?

  • Does the state require physician ownership of the medical practice entity?
  • Does the state require on-site physician presence, or is remote supervision permitted?
  • What is the chart review and protocol oversight requirement?
  • How is the medical director role audited or enforced by the state medical board?

3. What is the post-close continuity plan?

  • Will the current medical director continue under the buyer’s structure?
  • If not, who is the successor and what is the credentialing timeline?
  • What is the gap risk between close and the new medical director taking over?

4. What are the structural arrangements?

  • Is there an MSO/PC structure in place?
  • Is the management services agreement current, signed, and defensible?
  • Are the management fees defensible as fair market value for actual services?
  • Has the structure been reviewed by qualified healthcare counsel?

5. What is the historical compliance posture?

  • Any medical board complaints or investigations?
  • Any patient incidents that triggered regulatory inquiries?
  • Any audits, surveys, or enforcement actions?
  • Any history of staffing changes that suggest supervisory gaps?

The combined answer to these five lines of inquiry is what determines whether a deal can close, what the timeline looks like, and what the multiple gets discounted by if there are issues.

The workable solutions

For each of the four scenarios, there are defined solutions that buyers will accept.

For owner-physician sellers (Scenario 1)

Solution A — Long employment with rollover. You stay on as Chief Medical Officer or equivalent for 36–60 months under an employment agreement with significant equity rollover into platform. This is the standard structure for dermatology platform deals and similar transactions. Best for owners who want a “second bite of the apple” through platform exit.

Solution B — Transition agreement. You stay on as medical director for 12–24 months on a defined contract, with handoff to a successor identified during the transition period. Best for owners who want to exit faster than a long employment agreement allows.

Solution C — Pre-sale succession. You hire and credential an associate medical director 12–18 months before sale, transition supervisory responsibilities, and present a clean continuity story to buyers. The most expensive in calendar time but produces the highest multiples and the cleanest exit terms.

For sellers with continuing contracted medical director (Scenario 2)

Solution: Confirm the medical director’s commitment in writing before going to market. Include a buyer-compatible employment or contractor agreement template in the data room. The smoothest scenario in the universe.

For sellers with departing or uncertain medical director (Scenario 3)

Solution A — Identify the successor before market launch. Source a candidate physician 90–180 days before going to market, get them credentialed, build the relationship, and have a written transition plan ready for buyers on day one. This is what specialist advisors help with.

Solution B — Buyer-supplied medical director. Limit the buyer universe to platforms that have their own medical director infrastructure. PE-backed med spa platforms typically can drop in a designated physician at close. This narrows the buyer pool but can work for the right deal.

For sellers in informal medical director arrangements (Scenario 4)

Solution: Remediate first, sell second. The structural cleanup typically takes 6–12 months and involves: formalizing a real medical director relationship, restructuring the MSO/PC arrangement under current best practices, documenting protocols and chart review procedures, and aligning the practice with state-specific CPOM requirements. This is unglamorous work but it is the difference between a practice that can be sold and a practice that cannot.

Potential Deal Consequences

A documented oversight or continuity defect may require legal analysis, revised agreements, a successor provider, delayed closing, changed deal structure, or buyer risk protections. The effect on timing or value is fact-specific.

What to do now

If you are 12–24 months from sale, three concrete actions:

1. Get an honest assessment of your medical director situation. Which of the four scenarios are you in? If you don’t know, that’s the first conversation.

Have qualified healthcare counsel review the entity structure, agreements, delegation, supervision, compensation, and applicable state requirements. Scope, cost, timing, and outcome vary.

2. Build the continuity plan. Whether that’s hiring an associate medical director, locking down your existing relationship in writing, or planning your post-close role — have the plan in place before you start talking to buyers. Buyers ask the question on the first call.

Frequently asked questions

I’m a non-physician owner. Can I really sell my med spa if I’m the medical director?

You probably can’t be the medical director if you’re not a physician — that’s the structural issue, regardless of whether you’re selling. If your practice has been operating with this gap, the first step is remediation, not sale. Talk to a healthcare attorney who knows your state.

My medical director is willing to continue post-close. Is that enough?

It’s most of the way there. The remaining work is documenting their commitment in a way the buyer can rely on, structuring an employment or contractor agreement that aligns with the buyer’s framework, and confirming that no state-specific issues will arise from the change of ownership.

What if the buyer wants to install their own medical director?

That’s fine for many transactions and is the standard approach for PE-backed platform tuck-ins. The main question is the credentialing timeline and the gap risk between close and the new medical director taking over. Both are addressable with planning.

How does this issue work when an NP or PA provides care?

Ownership, prescribing, delegation, and supervision depend on state law and provider type. Texas law regulates physician delegation of prescriptive authority and should not be described broadly as an independent-practice or “NP-friendly” ownership model. Review the exact state, services, licenses, and agreements with qualified counsel.


Related reading:

What Is Your Med Spa Worth?

Get a free, confidential valuation from a specialist M&A firm. No obligation. Written range delivered within two business days.

Get a Free Med Spa Valuation →